Stem cell transplant in young adults and adolescents with severe sickle cell disease may be a feasible option, according to a ...
Jan. 17, 2025 — A new study has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals. A brain image from a ...
DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...
Aruvant is developing ARU-1801, a one-time, potentially curative gene therapy for sickle ... functional fetal hemoglobin in β-thalassemia patients and restore normal red blood cell function.
IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...
IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...
This leads to leads to anemia, as well as congestion ... fraction of RBCs still contain a mixture of fetal and adult hemoglobin. Because the sickle-cell mutation is present only on the β-globin ...
New data from a Phase 1b clinical trial testing Fulcrum's pociredir for sickle cell disease are expected by the middle and ...
Hydroxyurea Significantly Reduces Infections in Children With Sickle Cell Anemia Jan. 29, 2024 — Researchers have revealed that hydroxyurea significantly reduces infections in children with ...
YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204, an investigational therapy for the ...
The knowledge and awareness of genotype must start from the parents, adding that this understanding would aid the transfer of ...
Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...